+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of insulin regimens in the therapy of type 1 diabetes



Comparison of insulin regimens in the therapy of type 1 diabetes



Acta Endocrinologica. Supplementum 272: 49-55



The major problems with one or two daily subcutaneous injections of fast and intermediate acting insulins are morning hyperglycaemia and nocturnal hypoglycaemia. These problems can be avoided to a great extent by giving a third injection at bedtime. However, the kinetics of plasma free insulin during these insulin regimens is unphysiological and appropriate meal related plasma insulin peaks cannot be achieved. The new intensified methods of insulin delivery, multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII) are more physiological. Consequently, a near normal glycaemic control can be achieved with these regimens; more often with CSII than with MDI. The risk of complications of CSII is on the other hand slightly greater. The importance and need of intensified insulin therapy in the treatment of insulin dependent diabetes is not yet fully settled. At the present it is not a primary form of treatment and indicated only if the conservative insulin regimens fail.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039630441

Download citation: RISBibTeXText

PMID: 3914804

DOI: 10.1530/acta.0.110s049


Related references

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs. Diabetes Obesity and Metabolism 10(12): 1178-1185, 2008

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Clinical Therapeutics 29 Spec No: 1254-1270, 2007

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 23(9): 1232-1235, 2000

A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes. Diabetes Obesity and Metabolism 15(12): 1120-1127, 2013

Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps. Pediatric Diabetes 15(5): 329-335, 2014

Comparison of insulin regimens for patients with type 2 diabetes. Current Opinion in Endocrinology & Diabetes 7(4): 175-183, 2000

Comparison of additional lunch and bedtime NPH insulin to mealtime insulin lispro therapy with premeal regular insulin plus NPH insulin therapy in type 2 diabetes. Diabetes & Metabolism 29(Hors serie 2): 4S225-4S226, 2003

Comparison of postprandial unmodified insulin with nph insulin administration before bedtime and conventional insulin therapy in the combination therapy with insulin sulfonylurea in type ii diabetes. Bachmann, W , N Lotz And H Mehnert (Ed ) Insulin/Sulfonylharnstoff: Kombinationstherapie Bei Typ-Ii-Diabetes (Insulin/Sulfonylurea: Combination Therapy in Type Ii Diabetes); 2nd Symposium, Munich, West Germany, October 28, 1986 Viii+167p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 71-80, 1988

A comparison of three different insulin regimens in multiple insulin injection therapy of type 1 diabetic patients. Acta Endocrinologica Suppl. 120(2): 31, 1989

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Research and Clinical Practice 108(2): 350-359, 2015

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Diabetes Care 23(8): 1137-1142, 2000

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens. Endocrinología y Nutrición (English Edition) 60(5): 249-253, 2013

Computerized generation of circadian sensor modal days with continuous glucose monitoring for comparison of various insulin regimens based on insulin glargine in type 1 diabetes. International Journal of Artificial Organs 26(8): 728-734, 2003

Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Endocrine 51(3): 417-428, 2016

Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes. Diabetes Obesity and Metabolism 12(11): 967-975, 2010